Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

340B And US Drug Pricing: Trump’s First Target Is One That Lasts

Aug 06 2020

• By Michael McCaughan

On Target, Target hit in the center by arrows

Related Content

Biopharma, the White House And Getting Drug Pricing ‘Off The Table’

Jul 29 2020

Presidential Arm Twisting: Drug Pricing Order Would Advance International Benchmarks Unless Industry Offers Alternative

Jul 25 2020

340B Payment Cut Overturned By US Federal Court; What Comes Next?

Jan 04 2019

Medicare Lowers Payments For 340B Drugs: Promising Sign For Further Reform?

Nov 02 2017

HHS Secretary Tom Price Resigns Over Free-Flights Flap

Sep 30 2017

Related Companies

Eli Lilly and Company

Additional Topics

United States Pricing Debate Politics Government Payers Reimbursement Policy BioPharmaceutical

More from Medicare

More from Government Payers

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.